Clinical Trials Directory

Trials / Completed

CompletedNCT04726098

Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19

Efficacy of Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
198 (actual)
Sponsor
Manuel Taboada Muñiz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

After RECOVERY trial publication, low dose (6 mg dexamethasone for 10 days) was recommended as the usual care treatment in hospitalized patients with respiratory failure by COVID-19 needing oxygen therapy. RECOVERY trial showed how the use of dexamethasone 6 mg / day for ten days compared to standard treatment without the use of corticosteroids in hospitalized patients reduced mortality at 28 days (22.9% with dexamethasone vs 25.7% without dexamethasone). In the dexamethasone group, the incidence of mortality was lower than standard treatment in patients with hypoxia and the need for mechanical ventilation (29.3% with dexamethasone vs 41.4% without dexamethasone), in patients admitted to the hospital ward with a need for oxygen therapy (23.3% with dexamethasone vs 26.2% without dexamethasone), but they did not find differences between those admitted patients who did not need oxygen therapy. There are two other studies (DEXA-COVID-19 and CoDEX) where they observed benefits of the use of dexamethasone 20 mg / day 5 days, and 10 mg / day 5 days (total 10 days) in patients admitted for respiratory distress syndrome (ARDS) and COVID-19. At present, it is unclear what dose of dexamethasone is most beneficial in patients with COVID-19 and respiratory failure.

Detailed description

Objective: The investigators aim to assess the efficacy of high dose of dexamethasone (20 mg / day 5 days, and 10 mg/day 5 days) versus low dose of dexamethasone (6 mg/day 10 days) in patients with respiratory failure by COVID-19.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone high doseHigh doses: dexamethasone 20 mg/day 5 days + 10 mg/day 5 days (total 10 days)
DRUGDexamethasone low doseLow doses: dexamethasone 6 mg/day 10 days.

Timeline

Start date
2021-01-15
Primary completion
2021-08-31
Completion
2021-08-31
First posted
2021-01-27
Last updated
2021-10-20

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04726098. Inclusion in this directory is not an endorsement.